Connect with us

Business

Genmab announces the launch of a share buyback program on the Copenhagen Stock Exchange: GEN

Avatar

Published

on


Company announcement

  • Buyback of up to 200,000 shares
  • Mitigate dilution due to exercise of warrants and honor commitments under our restricted stock unit program
  • Completion expected by June 30, 2021

Copenhagen, Denmark; February 23, 2021 Genmab A / S (Nasdaq: GMAB) today announced the launch of a share buyback program to mitigate dilution from exercise of warrants and honor our commitments under our restricted share unit program. The share buyback program will be undertaken under the conditions set out below and in accordance with Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also known as the Safe Harbor. Regulation.

Goal
The purpose of the share repurchase program is to mitigate the dilution caused by the exercise of warrants and to honor our commitments under our restricted share unit program.

Time Frame
The share buyback program will begin on February 24, 2021 and end no later than June 30, 2021 (unless Genmab terminates or suspends the program).

terms
Genmab has appointed Danske Bank as lead manager of the share buyback program. Danske Bank will make its own business decisions and will act independently and without the influence or involvement of Genmab. As part of this share buyback program, Genmab can buy back up to 200,000 shares.

Shares acquired under the program cannot be purchased at a price greater than the higher of (i) the price of the last independent transaction on Nasdaq Copenhagen and (ii) the price of the most independent offer. high on the Nasdaq Copenhagen at the time of the transaction. The total number of shares that can be purchased on a single trading day cannot exceed 25% of the average daily trading volume over the previous 20 trading days on the Nasdaq Copenhagen.

As of February 23, 2021, Genmab held 102,977 treasury shares representing 0.16% of the share capital.

Genmab is entitled to suspend or terminate the program at any time subject to an announcement at Nasdaq Copenhagen.

When the program is launched, Genmab will publish a weekly announcement regarding transactions made under the program.

About Genmab
Genmab is an international biotechnology company whose primary goal is to improve the lives of cancer patients. Founded in 1999, Genmab is the creator of several approved therapeutic antibodies which are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next generation antibody technologies, expertise in antibody biology, translational research and data science and strategic partnerships. To create new therapies, Genmab uses its next generation antibody technologies, which are the result of its collaborative corporate culture and a deep passion for innovation. Genmabs’ proprietary pipeline consists of engineered antibody candidates, including bispecific T-cell gear and next-generation immune checkpoint modulators, effector-enhanced antibodies, and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark, with sites in Utrecht, the Netherlands, Princeton, New Jersey, the United States and Tokyo, Japan. For more information, please visit Genmab.com.

Contact:
Marisol Peron, Senior Vice President, Global Investor Relations and Communications
T: +1 609 524 0065; E: [email protected]

For investor relations:
Andrew Carlsen, Senior Director, Head of Investor Relations
T: +45 3377 9558; E: [email protected]

This company announcement contains forward-looking statements. The words believe, expect, anticipate, intend and plan and similar expressions identify forward-looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied in such statements. Important factors that could cause our actual results or performance to vary materially include, but are not limited to, risks associated with preclinical and clinical product development, uncertainties associated with the results and conduct of clinical trials, including unforeseen safety issues, uncertainties related to the product manufacturing, the lack of acceptance of our products in the market, our inability to manage growth, the competitive environment in relation to our industry and our markets, our inability to attract and retain suitably qualified personnel, the inapplicability or lack of protection of our patents and rights, our relationships with affiliated entities, changes and technological developments that may render our products or technologies obsolete, and other factors. For a more in-depth discussion of these risks, please refer to the risk management sections of Genmabs’ latest financial reports, available at www.genmab.com and the risk factors included in Genmabs latest annual report on Form 20-F and other filings from the United States Securities and Exchange Commission (SEC), available at www.sec.gov. Genmab assumes no obligation to update or revise any forward-looking statements in this Company Announcement or to confirm such statements to reflect subsequent events or circumstances after the date of publication or in connection with actual results, unless the law requires it.

Genmab A / S and / or its subsidiaries own the following brands: Genmab; the Y-shaped Genmab logo; Genmab in combination with the Y-shaped Genmab logo; HuMax; DuoBody; DuoBody in combination with the DuoBody logo; HexaBody; HexaBody in combination with the HexaBody logo; DuoHexaBody; HexElect; and UniBody.

Company announcement no. 11
CVR no. 2102 3884
LEI code 529900MTJPDPE4MHJ122

Genmab A / S
Kalvebod Brygge 43
1560 Copenhagen V
Denmark

  • 210223_CA_11_Share_Buyback

What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos



picture credit

ExBUlletin

to request, modification Contact us at Here or [email protected]